Search research articles
Contact Us
Filters
Showing results (161-170 of 413) with videos related to
Page
of 42
Sort By:
Cancer Immunology, Immunotherapy : CII
|
January 1, 1988
The augmentation of tumor-specific immunity using haptenic muramyl dipeptide (MDP) derivatives. III. Eradication of disseminated murine chronic leukemia cells by utilizing MDP hapten-reactive helper T-cell activity
J Shima, T Yoshioka, H Nakajima, et al.
Thymus
|
June 1, 1993
Thymic stroma-derived T-cell inhibitory factor (TSTIF). 2: TSTIF acts on the antigen-presenting cell to inhibit antigen-stimulated T-cell proliferation
X G Tai, Y Kita, K Toyooka, et al.
The American Journal of Physiology
|
March 1, 1992
Recovery from exercise-induced desaturation in the quadriceps muscles of elite competitive rowers
B Chance, M T Dait, C Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 15, 1992
Instability of assembled T-cell receptor complex that is associated with rapid degradation of zeta chains in immature CD4+CD8+ thymocytes
A Kosugi, A M Weissman, M Ogata, et al.
Japanese Journal of Cancer Research : Gann
|
March 1, 1991
Antigen-presenting cells constitutively bind tumor antigens in the tumor-bearing state in vivo to construct an effective immunogenic unit
J Shimizu, J P Zou, K Ikegame, et al.
Journal of the National Cancer Institute
|
June 1, 1985
Genetic control of hapten-reactive helper T-cell responses and its implications for the generation of augmented antitumor cytotoxic responses
Y Mizushima, H Fujiwara, Y Takai, et al.
International Immunology
|
December 1, 2000
Requirement for IFN-gamma in IL-12 production induced by collaboration between v(alpha)14(+) NKT cells and antigen-presenting cells
Y F Yang, M Tomura, S Ono, et al.
Transplantation
|
April 1, 1987
Tolerance induction of alloreactivity by portal venous inoculation with allogeneic cells followed by the injection of cyclophosphamide. I. Specific suppression of alloreactive cytotoxic and delayed-type hypersensitivity responses as well as allograft rejection
J H Qian, S Kokudo, S Sato, et al.
International Archives of Allergy and Applied Immunology
|
January 1, 1981
Immunological properties of Fc receptor on lymphocytes. 9. Functional analysis of FcR gamma+ and FcR gamma- lymphocytes in IgE antibody responses
M Miyama-Inaba, T Masuda, T Inada, et al.
Journal of the National Cancer Institute
|
December 1, 1986
Augmentation of antitumor immune response by trinitrophenyl (TNP)-reactive helper T-cells: enhanced induction of tumor-specific Lyt-1+2- T-cell-mediated delayed-type hypersensitivity from spleen cells of tumor-bearing mice by TNP helpers
T Suda, H Fujiwara, Y Mizushima, et al.
Page
of 42
Search research articles
Search
Showing results (161-170 of 413) with videos related to
Sort By:
Page
of 42
Cancer Immunology, Immunotherapy : CII
|
January 1, 1988
The augmentation of tumor-specific immunity using haptenic muramyl dipeptide (MDP) derivatives. III. Eradication of disseminated murine chronic leukemia cells by utilizing MDP hapten-reactive helper T-cell activity
J Shima, T Yoshioka, H Nakajima, et al.
Thymus
|
June 1, 1993
Thymic stroma-derived T-cell inhibitory factor (TSTIF). 2: TSTIF acts on the antigen-presenting cell to inhibit antigen-stimulated T-cell proliferation
X G Tai, Y Kita, K Toyooka, et al.
The American Journal of Physiology
|
March 1, 1992
Recovery from exercise-induced desaturation in the quadriceps muscles of elite competitive rowers
B Chance, M T Dait, C Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 15, 1992
Instability of assembled T-cell receptor complex that is associated with rapid degradation of zeta chains in immature CD4+CD8+ thymocytes
A Kosugi, A M Weissman, M Ogata, et al.
Japanese Journal of Cancer Research : Gann
|
March 1, 1991
Antigen-presenting cells constitutively bind tumor antigens in the tumor-bearing state in vivo to construct an effective immunogenic unit
J Shimizu, J P Zou, K Ikegame, et al.
Journal of the National Cancer Institute
|
June 1, 1985
Genetic control of hapten-reactive helper T-cell responses and its implications for the generation of augmented antitumor cytotoxic responses
Y Mizushima, H Fujiwara, Y Takai, et al.
International Immunology
|
December 1, 2000
Requirement for IFN-gamma in IL-12 production induced by collaboration between v(alpha)14(+) NKT cells and antigen-presenting cells
Y F Yang, M Tomura, S Ono, et al.
Transplantation
|
April 1, 1987
Tolerance induction of alloreactivity by portal venous inoculation with allogeneic cells followed by the injection of cyclophosphamide. I. Specific suppression of alloreactive cytotoxic and delayed-type hypersensitivity responses as well as allograft rejection
J H Qian, S Kokudo, S Sato, et al.
International Archives of Allergy and Applied Immunology
|
January 1, 1981
Immunological properties of Fc receptor on lymphocytes. 9. Functional analysis of FcR gamma+ and FcR gamma- lymphocytes in IgE antibody responses
M Miyama-Inaba, T Masuda, T Inada, et al.
Journal of the National Cancer Institute
|
December 1, 1986
Augmentation of antitumor immune response by trinitrophenyl (TNP)-reactive helper T-cells: enhanced induction of tumor-specific Lyt-1+2- T-cell-mediated delayed-type hypersensitivity from spleen cells of tumor-bearing mice by TNP helpers
T Suda, H Fujiwara, Y Mizushima, et al.
Page
of 42